These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 12921242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
    Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R.
    J Infect Dis; 2006 Sep 01; 194(5):710-3. PubMed ID: 16897672
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.
    González GM, González G, Najvar LK, Graybill JR.
    J Antimicrob Chemother; 2007 Dec 01; 60(6):1341-6. PubMed ID: 17934204
    [Abstract] [Full Text] [Related]

  • 4. In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes.
    Van der Auwera P, Meunier F.
    J Antimicrob Chemother; 1989 Nov 01; 24(5):747-63. PubMed ID: 2557318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J, Armstrong D, Lyman CA, Walsh TJ.
    J Clin Microbiol; 2005 Aug 01; 43(8):3788-92. PubMed ID: 16081911
    [Abstract] [Full Text] [Related]

  • 10. Caspofungin: a review of its use in the treatment of fungal infections.
    McCormack PL, Perry CM.
    Drugs; 2005 Aug 01; 65(14):2049-68. PubMed ID: 16162025
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S, Sancak B, Hascelik G.
    Med Mycol; 2005 Mar 01; 43(2):171-8. PubMed ID: 15832560
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model.
    Kohler S, Wheat LJ, Connolly P, Schnizlein-Bick C, Durkin M, Smedema M, Goldberg J, Brizendine E.
    Antimicrob Agents Chemother; 2000 Jul 01; 44(7):1850-4. PubMed ID: 10858342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C, Valverde-Conde A, Chávez M M, Bernal S, Claro RM, Pemán J, Ramirez M, Martín-Mazuelos E.
    Diagn Microbiol Infect Dis; 2003 Feb 01; 45(2):131-5. PubMed ID: 12614985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.